Palisade Bio Inc (NASDAQ:PALI) price on current trading day, fall -7.95% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.62.
A look at the stock’s price movement, the level at last check in today’s session was $1.76, moving within a range at $1.51 and $1.76. The beta value (5-Year monthly) was 1.331. Turning to its 52-week performance, $22.35 and $1.38 were the 52-week high and 52-week low respectively. Overall, PALI moved -8.47% over the past month.
Palisade Bio Inc’s market cap currently stands at around $4.48 million, with investors looking forward to this quarter’s earnings report slated for in February.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PALI is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend PALI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PALI’s current price about -11.40% and -22.68% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.40, while 7-day volatility ratio is 15.07% and 15.05% in the 30-day chart. Further, Palisade Bio Inc (PALI) has a beta value of 1.45, and an average true range (ATR) of 0.29. Analysts have given the company’s stock an average 52-week price target of $1.5, forecast between a low of $1.5 and high of $1.5. Looking at the price targets, the low is 7.41% off recent price level in today’s trading while to achieve the yearly target high, it has to move 7.41%. Nonetheless, investors will most likely welcome a 7.41% jump to $1.5 which is the analysts’ median price.
If we refocus on Palisade Bio Inc (NASDAQ:PALI), historical trading data shows that trading volumes averaged 0.36 over the past 10 days and 1.34 million over the past 3 months. The company’s latest data on shares outstanding shows there are 2.77 million shares.
The 0.81% of Palisade Bio Inc’s shares are in the hands of company insiders while institutional holders own 2.25% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 43112.0 on 2024-10-31, giving us a short ratio of 0.29. The data shows that as of 2024-10-31 short interest in Palisade Bio Inc (PALI) stood at 327.0 of shares outstanding, with shares short rising to 23930.0 registered in 2024-09-30. Current price change has pushed the stock -1.82% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PALI stock continues to rise going into the next quarter.
